NationalICMR Distances Itself From BHU's 'Poorly Designed' Study On Covaxin Side EffectsBY Asmita Ravi Shankar
NationalAfter Covishield, Now Covaxin Hits Headlines Over 'Health Issues' In 30% Of Those JabbedBY Outlook Web Desk
NationalBharat Biotech Highlights Covaxin's 'Safety First' Feature Amid AstraZeneca's Covishield Row Over Side EffectsBY Outlook Web Desk
NationalBharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality IssuesBY Outlook Web Desk
Art & EntertainmentManoj Bajpayee To Narrate 'The Vial', Documentary On India's Covid Vax SuccessBY IANS
National3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospitals: Bharat Biotech's Krishna EllaBY PTI
NationalBharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private And Rs 325 For Govt SuppliesBY PTI
NationalNasal Vaccine Against Covid-19 To Be Available On CoWIN: All You Need To KnowBY Outlook Web Desk
NationalRoutine Immunisation Suffered Due To Covid-19, It Has To Be Put Back On Track: MandaviyaBY PTI
InternationalUSA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side EffectsBY Outlook Web Desk
NationalBharat Biotech's Covid Nasal Vaccine Gets Nod For Emergency Use: All You Need To KnowBY Outlook Web Desk
NationalNTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 YearsBY Outlook Web Desk
NationalBharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEABY Outlook Web Desk
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook Web Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook Web Desk
NationalCOVID Vaccine Precaution Dose: Serum Institute, Bharat Biotech Cut Prices To Rs 225BY Outlook Web Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook Web Desk
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
